Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jade Ghosn

Showing results (111-120 of 267) with videos related to

Pageof 27
Sort By:
Substance Abuse Treatment, Prevention, and Policy|August 25, 2025
Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction servicesLuis Sagaon-Teyssier, Maxime Hoyer, Cécile Donadille, et al.
Frontiers in Public Health|January 29, 2024
Proof of concept of a sexual health outreach program led by community health workers in homeless hostels in the greater Paris regionEmma Vaugoyeau, Lison Rambliere, Manon David, et al.
AIDS (London, England)|August 5, 2010
Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimenConstance Delaugerre, Isabelle Charreau, Josephine Braun, et al.
The Journal of Antimicrobial Chemotherapy|July 22, 2008
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 TrialClaudine Duvivier, Jade Ghosn, Lambert Assoumou, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2012
Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIVStéphanie Dominguez, Jade Ghosn, Bruno Cassard, et al.
AIDS Research and Human Retroviruses|October 20, 2020
Prevalence of Silent Atherosclerosis and Other Comorbidities in an Outpatient Cohort of Adults Living with HIV: Associations with HIV Parameters and BiomarkersJade Ghosn, Hendy Abdoul, Soraya Fellahi, et al.
BMJ Medicine|March 20, 2023
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational studyMatthieu Legrand, Nicholas Fong, Cédric Laouénan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 28, 2020
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University HospitalValentina Isernia, Zelie Julia, Sylvie Le Gac, et al.
Journal of Medical Virology|August 16, 2022
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case reportLucas Khellaf, Fabrice Bouscarat, Sonia Burrel, et al.
Journal of Medical Virology|December 21, 2006
Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS studyStephanie Dominguez, Jade Ghosn, Gilles Peytavin, et al.
Pageof 27

Showing results (111-120 of 267) with videos related to

Sort By:
Pageof 27
Substance Abuse Treatment, Prevention, and Policy|August 25, 2025
Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction servicesLuis Sagaon-Teyssier, Maxime Hoyer, Cécile Donadille, et al.
Frontiers in Public Health|January 29, 2024
Proof of concept of a sexual health outreach program led by community health workers in homeless hostels in the greater Paris regionEmma Vaugoyeau, Lison Rambliere, Manon David, et al.
AIDS (London, England)|August 5, 2010
Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimenConstance Delaugerre, Isabelle Charreau, Josephine Braun, et al.
The Journal of Antimicrobial Chemotherapy|July 22, 2008
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 TrialClaudine Duvivier, Jade Ghosn, Lambert Assoumou, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2012
Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIVStéphanie Dominguez, Jade Ghosn, Bruno Cassard, et al.
AIDS Research and Human Retroviruses|October 20, 2020
Prevalence of Silent Atherosclerosis and Other Comorbidities in an Outpatient Cohort of Adults Living with HIV: Associations with HIV Parameters and BiomarkersJade Ghosn, Hendy Abdoul, Soraya Fellahi, et al.
BMJ Medicine|March 20, 2023
Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational studyMatthieu Legrand, Nicholas Fong, Cédric Laouénan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 28, 2020
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University HospitalValentina Isernia, Zelie Julia, Sylvie Le Gac, et al.
Journal of Medical Virology|August 16, 2022
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case reportLucas Khellaf, Fabrice Bouscarat, Sonia Burrel, et al.
Journal of Medical Virology|December 21, 2006
Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS studyStephanie Dominguez, Jade Ghosn, Gilles Peytavin, et al.
Pageof 27